Zhengxi Biotech announced that it has received $3,100,000 in a round of funding from Zhejiang Orient Gene Biotech Co., Ltd. on June 8, 2022.
Zhejiang Orient Gene Biotech Co.,Ltd
Equities
688298
CNE100003RM8
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.38 CNY | -0.67% | -5.93% | -20.64% |
05-16 | Orient Gene Biotech's US Unit Gets FDA Clearance for Fentanyl Detectors | MT |
04-29 | Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.64% | 790M | |
-4.92% | 12.27B | |
-5.82% | 7.99B | |
+5.43% | 5.69B | |
+26.16% | 5.42B | |
-9.58% | 4.13B | |
-59.63% | 2.7B | |
+8.44% | 2.6B | |
-3.70% | 2.38B | |
+21.00% | 2.1B |
- Stock Market
- Equities
- 688298 Stock
- News Zhejiang Orient Gene Biotech Co.,Ltd
- ZXBio, Inc. announced that it has received $3.1 million in funding from Zhejiang Orient Gene Biotech Co., Ltd.